Austrian biotech Marinomed is weighing up strategic options for its virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo, Reckitt and Procter & Gamble for use in OTC nasal sprays.
Having appointed an external advisor, Marinomed said it has initiated a process to begin engaging with interested parties to discuss...